title: The diagnosis and management of factor VIII and IX inhibitors: a guideline from the UK Haemophilia Centre Doctors' Organization (UKHCDO).
authors.affiliation: Manchester Haemophilia Comprehensive Care Centre, University Department of Haematology, Manchester Royal Infirmary, UK. haemophilia@man.ac.uk
authors.forename: C R
authors.initials: CR
authors.lastname: Hay
authors.forename: T P
authors.initials: TP
authors.lastname: Baglin
authors.forename: P W
authors.initials: PW
authors.lastname: Collins
authors.forename: F G
authors.initials: FG
authors.lastname: Hill
authors.forename: D M
authors.initials: DM
authors.lastname: Keeling
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000097:blood*; D019774:Blood Coagulation Factor Inhibitors / Q000032:analysis*; D002648:Child; D005164:Factor IX / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000276:immunology; D005169:Factor VIII / Q000032:analysis / Q000037:antagonists & inhibitors* / Q000276:immunology; D006207:Half-Life; D006467:Hemophilia A / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D002836:Hemophilia B / Q000097:blood* / Q000175:diagnosis / Q000628:therapy; D006488:Hemostasis, Surgical; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D007108:Immune Tolerance; D010314:Partial Thromboplastin Time; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D019774:Blood Coagulation Factor Inhibitors; D006490:Hemostatics; D011994:Recombinant Proteins; D005169:Factor VIII; D005164:Factor IX